-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
News in Brief - July 2025
- Thread starter S4ME News
- Start date
-
- Tags
- news news in brief
Week beginning 30th June 2025
News, advocacy and articles
Trial by Error by David Tuller Updated Medical Textbook Still Promotes Biopsychosocial Ideology
On the recent 11th edition of Elsevier's "Kumar & Clark's Clinical Medicine", a standard textbook for medical education worldwide. It places ME/CFS under "General Hospital Psychiatry" and claims psychological symptoms are core components of the illness as well as recommending the PACE trial for further reading. Tuller calls the section on ME/CFS "pathetic".
Article l Thread
UK government Welfare reforms Current planned legislation includes cuts to some benefits for sick and disabled people. The ME Association has produced a template letter to write to your MP. The organisation Benefits and Work also has useful information.
MEA template | Thread
UK NICE Clinical Knowledge Summary (CKS) on ME/CFS has been published. It summarises key points and provides guidance for clinicians. Forum discussion has raised serious issues with the document.
NICE CKS | Thread
UK Government Publication of the long delayed Delivery Plan for ME/CFS has been delayed again. Advocacy group #ThereForME give an update, saying they have been involved in the final stages and there is a plan, but no new funding.
Article | Thread
UK NHS apps for Long Covid and ME/CFS The UK government is funding development of apps by the private company Elaros in collaboration with Leeds and other NHS Long Covid services. The ME Association and the clinicians group BACME are collaborating in producing material for the apps, including one for ME/CFS clinics using the as yet unpublished ME Association supported Clinical toolkit and PROMs by Sarah Tyson. Meetings held recently by the MEA and Elaros have been for clinicians only. Elaros are inviting people with ME/CFS and related conditions to beta test the Open-OH app which is available in app stores and provide feedback. Forum members have found serious issues with the contents of the app.
Thread
UK Physios for ME mark six years working together, publication of their book, published and ongoing research, presentations, advocacy and support.
Article | Thread
Dr Michelle Bull, one of the four Physios for ME gave a talk hosted by Sheffeld ME/CFS and FM group at their AGM. "Using national and international best practice to improve services locally with special mention of physiotherapy." Duration 1 hour
Video | Thread
Mitt Eremitage The Swedish patient advocate and forum member Mitt Eremitage has written a thorough and critical article in five parts about a correspondence with the Bateman Horne Center on why their clinical guide includes a recommendation on brain training. Articles are in both English and Swedish versions.
Part 1 l Part 2 l Part 3 l Part 4 l Part 5 l Thread
Long Covid Advocacy The Danger of 'Feeling Safe': Long Covid and the Return of Psychosomatic Medicine
The third article of a brilliant series bringing historical context and critical analysis of the psychosomatic approach to Long Covid and ME/CFS.
Article l Thread
Solve ME Pacing: Power In Slowing Down (EmPOWER M.E. 2025)
A recording of the June 27 EmPower M.E. webinar has been posted on YouTube. A panel discusses pacing which is described as "one of the most talked-about — but often misunderstood — tools in chronic illness management."
Video | Thread
............
Research news and commentary
UK Action for ME: New Research Project: PRIME - Building infrastructure for Patients, Researchers and Industry for ME/CFS
"Started in October 2025, PRIME is funded by the Medical Research Council and is a 4 year project between Action for ME, the University of Edinburgh and the Genetics Centre of Excellence. A total of £843,662.40 will fund all partners' to the application over the 4 years." The aims are to create research collaborations; form international consortia on genetics and molecular biomarkers; and to build a PPI (public and patient involvement) of at least 100 people with ME/CFS and carers as a pool for researchers.
Article | Thread
.............
Research
ME/CFS research
Thesis: University of Surrey
Characterising the Electrophysiological Properties of Cells in Health and Disease — Krista Clarke
"Three candidates of diagnostic biomarkers were identified including ’normalised D value’ following hyperosmotic NaCl incubation, the magnitude of the percentage change in ζ-potential following hyperosmotic NaCl incubation, and the percentage changes in ζ-potential following hyperosmotic mannitol incubation. The latter biomarker performed the best, with a sensitivity and specificity of 92.31 and 71.43 respectively. Combining all three together produces an optimum performing biomarker with a sensitivity of 81.80% and a specificity of 85.70%. These results compare favourably with other biomarkers for ME/CFS."
Article | Thread
Artificial Intelligence in the Life Sciences
Actively protective combinatorial analysis: A scalable novel method for detecting variants that contribute to reduced disease prevalence in high-risk individuals — Sardell et al.
"the actively protective analysis supports the mechanistic hypotheses from our original causative combinatorial analysis for ME/CFS. It also identified several novel genes not identified in that analysis. Importantly, the signatures associated with these genes are associated with reduced rather than increased prevalence of ME/ CFS, especially among individuals who possess multiple causative risk signatures."
Article | Thread
Medical Research Journal
A systematic review of gut microbiota differences in ME/CFS and Long COVID patients — Hanna Tabisz et al.
"In both ME/CFS patients and LCS, an altered gut microbiota has been observed. Some studies have also reported reduced bacterial diversity and abundance compared to healthy individuals."
Article | Thread
Cureus
Nutraceutical Supplementation Effects on Subjective Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review — Emanuella M. Brito et al.
"This systematic review aims to evaluate and summarize recent evidence on nutrient supplementation and diet-based interventions in patients with ME/CFS sourced from clinical trial registries and article databases."
Article | Thread
Long Covid research
Gastro Hep Advances
Increased Risk of Post-Acute Sequalae of COVID-19 in Patients With Immune-Mediated Inflammatory Diseases — Evangelin Shaloom Vitus et al.
"In this population-based nationwide cohort study of 25,889 IMID patients and 51,778 matched non-IMID individuals, we report a significantly increased risk of developing PASC in patients living with one of the included IMIDs" "only those with [spondyloarthritis], [rheumatoid arthritis], and psoriasis were at a significantly higher risk of PASC."
Article | Thread
Nature Scientific Reports
Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms — Yukari Magawa et al.
"Collectively, our data demonstrate that LC following predominantly mild COVID-19 presents diverse symptoms affecting major organ systems, including the central nervous, pulmonary and cardiovascular systems. We show that different system-category symptoms are differentially associated with anti-SARS-CoV-2 antibody profiles, both in early convalescence and later, during ongoing LC symptoms, indicating both potentially protective and deleterious effects of anti-SARS-CoV-2 antibodies."
Article | Thread
Frontiers in Immunology
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cells — Abooali et al.
"Here, we report, for the first time, that Wuhan strain of SARSCoV-2 and its spike protein (S) induce activation of hypoxia-inducible factor 1 (HIF-1) transcription complex"
Article | Thread
Nature Scientific Reports
Mapping brain changes in post-COVID-19 cognitive decline via FDG PET hypometabolism and EEG slowing — Manganotti et al.
"The main finding of this study is the identification of significant hypometabolism and EEG slowing in anterior brain regions in patients with persistent subjective cognitive decline after mild COVID-19." "These findings were observed in patients who experienced mild acute COVID-19 that did not require hospitalization or ventilatory support."
Article | Thread
Circulation
Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association — William K. Cornwell et al.
Consensus statement promoting exercise therapy. "there is accumulating evidence that cardiovascular deconditioning is a central component of the pathophysiology. This deconditioning results from a relative reduction in physical activity in the setting of the index infection".
The cause of cardiovascular deconditioning in acutely *asymptomatic* cases does not appear to have been considered.
Article | Thread
...........
S4ME social media: Forum, Mastodon, Bluesky
News, advocacy and articles
Trial by Error by David Tuller Updated Medical Textbook Still Promotes Biopsychosocial Ideology
On the recent 11th edition of Elsevier's "Kumar & Clark's Clinical Medicine", a standard textbook for medical education worldwide. It places ME/CFS under "General Hospital Psychiatry" and claims psychological symptoms are core components of the illness as well as recommending the PACE trial for further reading. Tuller calls the section on ME/CFS "pathetic".
Article l Thread
UK government Welfare reforms Current planned legislation includes cuts to some benefits for sick and disabled people. The ME Association has produced a template letter to write to your MP. The organisation Benefits and Work also has useful information.
MEA template | Thread
UK NICE Clinical Knowledge Summary (CKS) on ME/CFS has been published. It summarises key points and provides guidance for clinicians. Forum discussion has raised serious issues with the document.
NICE CKS | Thread
UK Government Publication of the long delayed Delivery Plan for ME/CFS has been delayed again. Advocacy group #ThereForME give an update, saying they have been involved in the final stages and there is a plan, but no new funding.
Article | Thread
UK NHS apps for Long Covid and ME/CFS The UK government is funding development of apps by the private company Elaros in collaboration with Leeds and other NHS Long Covid services. The ME Association and the clinicians group BACME are collaborating in producing material for the apps, including one for ME/CFS clinics using the as yet unpublished ME Association supported Clinical toolkit and PROMs by Sarah Tyson. Meetings held recently by the MEA and Elaros have been for clinicians only. Elaros are inviting people with ME/CFS and related conditions to beta test the Open-OH app which is available in app stores and provide feedback. Forum members have found serious issues with the contents of the app.
Thread
UK Physios for ME mark six years working together, publication of their book, published and ongoing research, presentations, advocacy and support.
Article | Thread
Dr Michelle Bull, one of the four Physios for ME gave a talk hosted by Sheffeld ME/CFS and FM group at their AGM. "Using national and international best practice to improve services locally with special mention of physiotherapy." Duration 1 hour
Video | Thread
Mitt Eremitage The Swedish patient advocate and forum member Mitt Eremitage has written a thorough and critical article in five parts about a correspondence with the Bateman Horne Center on why their clinical guide includes a recommendation on brain training. Articles are in both English and Swedish versions.
Part 1 l Part 2 l Part 3 l Part 4 l Part 5 l Thread
Long Covid Advocacy The Danger of 'Feeling Safe': Long Covid and the Return of Psychosomatic Medicine
The third article of a brilliant series bringing historical context and critical analysis of the psychosomatic approach to Long Covid and ME/CFS.
Article l Thread
Solve ME Pacing: Power In Slowing Down (EmPOWER M.E. 2025)
A recording of the June 27 EmPower M.E. webinar has been posted on YouTube. A panel discusses pacing which is described as "one of the most talked-about — but often misunderstood — tools in chronic illness management."
Video | Thread
............
Research news and commentary
UK Action for ME: New Research Project: PRIME - Building infrastructure for Patients, Researchers and Industry for ME/CFS
"Started in October 2025, PRIME is funded by the Medical Research Council and is a 4 year project between Action for ME, the University of Edinburgh and the Genetics Centre of Excellence. A total of £843,662.40 will fund all partners' to the application over the 4 years." The aims are to create research collaborations; form international consortia on genetics and molecular biomarkers; and to build a PPI (public and patient involvement) of at least 100 people with ME/CFS and carers as a pool for researchers.
Article | Thread
.............
Research
ME/CFS research
Thesis: University of Surrey
Characterising the Electrophysiological Properties of Cells in Health and Disease — Krista Clarke
"Three candidates of diagnostic biomarkers were identified including ’normalised D value’ following hyperosmotic NaCl incubation, the magnitude of the percentage change in ζ-potential following hyperosmotic NaCl incubation, and the percentage changes in ζ-potential following hyperosmotic mannitol incubation. The latter biomarker performed the best, with a sensitivity and specificity of 92.31 and 71.43 respectively. Combining all three together produces an optimum performing biomarker with a sensitivity of 81.80% and a specificity of 85.70%. These results compare favourably with other biomarkers for ME/CFS."
Article | Thread
Artificial Intelligence in the Life Sciences
Actively protective combinatorial analysis: A scalable novel method for detecting variants that contribute to reduced disease prevalence in high-risk individuals — Sardell et al.
"the actively protective analysis supports the mechanistic hypotheses from our original causative combinatorial analysis for ME/CFS. It also identified several novel genes not identified in that analysis. Importantly, the signatures associated with these genes are associated with reduced rather than increased prevalence of ME/ CFS, especially among individuals who possess multiple causative risk signatures."
Article | Thread
Medical Research Journal
A systematic review of gut microbiota differences in ME/CFS and Long COVID patients — Hanna Tabisz et al.
"In both ME/CFS patients and LCS, an altered gut microbiota has been observed. Some studies have also reported reduced bacterial diversity and abundance compared to healthy individuals."
Article | Thread
Cureus
Nutraceutical Supplementation Effects on Subjective Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review — Emanuella M. Brito et al.
"This systematic review aims to evaluate and summarize recent evidence on nutrient supplementation and diet-based interventions in patients with ME/CFS sourced from clinical trial registries and article databases."
Article | Thread
Long Covid research
Gastro Hep Advances
Increased Risk of Post-Acute Sequalae of COVID-19 in Patients With Immune-Mediated Inflammatory Diseases — Evangelin Shaloom Vitus et al.
"In this population-based nationwide cohort study of 25,889 IMID patients and 51,778 matched non-IMID individuals, we report a significantly increased risk of developing PASC in patients living with one of the included IMIDs" "only those with [spondyloarthritis], [rheumatoid arthritis], and psoriasis were at a significantly higher risk of PASC."
Article | Thread
Nature Scientific Reports
Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms — Yukari Magawa et al.
"Collectively, our data demonstrate that LC following predominantly mild COVID-19 presents diverse symptoms affecting major organ systems, including the central nervous, pulmonary and cardiovascular systems. We show that different system-category symptoms are differentially associated with anti-SARS-CoV-2 antibody profiles, both in early convalescence and later, during ongoing LC symptoms, indicating both potentially protective and deleterious effects of anti-SARS-CoV-2 antibodies."
Article | Thread
Frontiers in Immunology
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cells — Abooali et al.
"Here, we report, for the first time, that Wuhan strain of SARSCoV-2 and its spike protein (S) induce activation of hypoxia-inducible factor 1 (HIF-1) transcription complex"
Article | Thread
Nature Scientific Reports
Mapping brain changes in post-COVID-19 cognitive decline via FDG PET hypometabolism and EEG slowing — Manganotti et al.
"The main finding of this study is the identification of significant hypometabolism and EEG slowing in anterior brain regions in patients with persistent subjective cognitive decline after mild COVID-19." "These findings were observed in patients who experienced mild acute COVID-19 that did not require hospitalization or ventilatory support."
Article | Thread
Circulation
Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV2 (Long COVID): A Scientific Statement From the American Heart Association — William K. Cornwell et al.
Consensus statement promoting exercise therapy. "there is accumulating evidence that cardiovascular deconditioning is a central component of the pathophysiology. This deconditioning results from a relative reduction in physical activity in the setting of the index infection".
The cause of cardiovascular deconditioning in acutely *asymptomatic* cases does not appear to have been considered.
Article | Thread
...........
S4ME social media: Forum, Mastodon, Bluesky
Week beginning 7th July 2025
News, advocacy and articles
#ThereForME The Tiger Who Came to Tea... and Stayed
An important article by Long Covid Advocacy on severe ME: ".. an inverse relationship occurs in ME. The greater the need, the fewer interventions one receives. The more the illness restricts your daily life, the less one is believed. We see a severity paradox, where injustice escalates fast."
Article l Thread
The Netherlands
David Tuller interview Dutch journalist Sander Zurhake about his recent critical publication concerning CBT in children with ME and long COVID. Zurhake works at the public broadcaster NOS. He explains how much resistance he and his editorial team received from The Dutch Association of Pediatrics for being critical about CBT.
Video | Thread
Sweden Patient advocate and forum member MittEremitage writes about worrying aspects of a lecture series in primary care on post-infectious conditions which is based on the controversial guidelines from the National Board of Health and welfare.
Article l Thread
Hungary
Several months ago, the scientific journal Orvosi Hetilap published new official Hungarian recommendation for the treatment of ME/CFS. However, Orvosi Hetilap received a letter from Jonathan Edwards, professor emeritus at University College London criticising the paper. In their reply, the authors admit that what they wrote in the recommendation does not align with NICE’s latest recommendations, and they no longer recommend the therapies they previously mentioned.
Article | Thread
#MEAction has announced their Severe ME Artists Project for 2025 in recognition of Severe ME Day on August 8th. Anyone who identifies as having severe ME can participate. Submissions are due by July 24.
Article | Thread
USA - Solve ME has an overview of this year's Advocacy Week 2025 on their website. There were a total of 187 meetings with congressional offices, with 226 attendees from across 36 states and Washington, D.C.
Article | Thread
The Sick Times Experts call new Canadian Long COVID guidelines “contradictory” and “deeply concerning”
This article describes problems with the new Long Covid guidelines which include scientifically unsupported therapies such as exercise and cognitive behavioral therapy. Experts say some of these guidelines could harm people with Long COVID.
Article | Thread
.............
Research news and commentary
UK National Institute for Health Research
"The Efficacy and Mechanism Evaluation (EME) Programme is accepting full applications for research looking into the treatment and management of post-acute infection syndromes and associated conditions, including long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)".
Applications close 2nd December 2025. This project is mentioned in a parliamentary written answer.
Information | Thread | Parliamentary answer
Germany
The MIRACLE research project is now recruiting participants. It will investigates immunological, inflammatory, and metabolic pathways in approximately 200 patients with ME/CFS and 200 healthy controls. The project is a collaboration between the University Hospital of Marburg (UKGM) and the University Hospital of Regensburg (UKR).
Article | Thread
The Sick Times Live Blog: Following the Patient-Led Research Fund summer 2025 webinar
Coverage of the July 9 webinar which covered "new findings about the underlying biology of infection-associated chronic conditions (IACCs), as well as discussions about how patient engagement leads to better research."
Blog | Thread
............
Research
ME/CFS research
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study — Fluge et al.
"We performed a prospective, open-label pilot trial" "Six out of 10 patients experienced clinical improvement during follow-up." "there was a significant correlation between baseline number of NK cells in peripheral blood and clinical improvement"
Article | Thread
Oxidative stress is a shared characteristic of ME/CFS and Long COVID — Shankar et al.
"Using a combination of flow cytometry, RNA-seq, mass spectrometry, and systems chemistry analysis, we observed aberrations in reactive oxygen species (ROS) clearance pathways including elevated glutathione levels, decreases in mitochondrial superoxide dismutase protein levels, and glutathione peroxidase 4–mediated lipid oxidative damage. Strikingly, these redox pathways changes show sex-specific trends."
Article | Thread
Patient-reported treatment outcomes in ME/CFS and long COVID — Eckey et al.
"This study analyzes patient-reported outcomes from over 3,900 individuals, identifying treatments perceived as beneficial and uncovering symptom-based patient subgroups with distinct responses to therapies. Notably, there is significant overlap in the symptom profiles and treatment responses between ME/CFS and long COVID, suggesting that they may share underlying mechanisms."
Article | Thread
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis — Rostami-Afshari et al.
"findings suggest that immune dysregulation in ME may be linked to enhanced cleavage of membrane-bound SMPDL3B by PI-PLC." However forum commentary identified that the study may suffer from inadquate matching between patients and controls.
Article | Thread
Comparing DNA Methylation Landscapes in Peripheral Blood from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Patients — Peppercorn et al.
"A comparative study of the DNA methylation changes in small cohorts of age/sex matched ME/CFS patients and LC patients was compared against similarly matched [healthy controls]."
Article | Thread
Decreased risk of chronic fatigue syndrome following influenza vaccine: a 20-year population-based retrospective study — Chang et al.
Study used a broad definition of CFS. "each cohort comprised 309,692 patients. Over an average follow-up period of approximately 12 years, influenza patients exhibited a significantly increased risk of developing CFS compared to matched controls (aHR = 1.51; 95% CI: 1.48–1.55; p < 0.001)."
Article | Thread
Multifaceted evolution focused on maximal exploitation of domain knowledge for the consensus inference of Gene Regulatory Networks — Segura-Ortiz et al.
"BIO-INSIGHT was applied to gene expression data from patients with fibromyalgia, myalgic encephalomyelitis, and co-diagnosis of both diseases. The inferred networks revealed regulatory interactions specific to each condition, suggesting its clinical utility in biomarker identification and potential therapeutic targets."
Article | Thread
Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia — Giménez -Orenga et al.
Article | Thread
Long Covid research
Immunological and Clinical Markers of Post-acute Sequelae of COVID-19: Insights from Mild and Severe Cases 6 Months Post-infection — William Mouton et al.
"an indepth analysis of immune parameters in severe patients with and without PASC highlighted that total and N/M-responsive memory T cells from patients with PASC harbored a more terminally differentiated phenotype."
Article | Thread
In Silico Analysis of Post-COVID-19 Condition (PCC) Associated SNP rs9367106 Predicts the Molecular Basis of Abnormalities in the Lungs and Brain Functions — Maiti
"rs9367106 carrying DNA sequences act as distant enhancers and bind with several transcription factors (TFs) including YY1, PPAR-α, IK-1, GR-α, and AP2αA. The G>C transition extensively modifies the RNA structure that may affect the TF bindings and enhancer functions to alter the interactions and functions of these RNA molecules."
Article | Thread
Comprehensive molecular characterization of post-COVID condition: Immunoglobulin suppression and persistent SARS-CoV-2 antigens as key pathophysiological drivers — Seco-Gonzalez et al.
Article | Thread
Validity of the test for attentional performance in neurological post-COVID condition — Seibert et al.
"The TAP subtests identified significant impairments in sustained attention and processing speed in one-third of PCC patients, surpassing traditional tests in sensitivity, and classifying PCC with an AUC of 78%."
Article | Thread
Appropriate Screening Tests to Assess Post-COVID-19 Cognitive Dysfunction in Aeromedical Settings — Solomon G. Beka et al.
"Based on evaluation of literature review findings and Delphi consultation with subject matter experts, the Trail Making Test and Symbol Digit Modalities Test were identified as quick and suitable screening tests likely to detect post-COVID-19 cognitive dysfunction."
Article | Thread
Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland — Kwon et al.
"This study found small improvements in EQ-5D-3L utility score in LC patients receiving care in LC clinics."
Article | Thread
...........
S4ME social media: Forum, Mastodon, Bluesky
News, advocacy and articles
#ThereForME The Tiger Who Came to Tea... and Stayed
An important article by Long Covid Advocacy on severe ME: ".. an inverse relationship occurs in ME. The greater the need, the fewer interventions one receives. The more the illness restricts your daily life, the less one is believed. We see a severity paradox, where injustice escalates fast."
Article l Thread
The Netherlands
David Tuller interview Dutch journalist Sander Zurhake about his recent critical publication concerning CBT in children with ME and long COVID. Zurhake works at the public broadcaster NOS. He explains how much resistance he and his editorial team received from The Dutch Association of Pediatrics for being critical about CBT.
Video | Thread
Sweden Patient advocate and forum member MittEremitage writes about worrying aspects of a lecture series in primary care on post-infectious conditions which is based on the controversial guidelines from the National Board of Health and welfare.
Article l Thread
Hungary
Several months ago, the scientific journal Orvosi Hetilap published new official Hungarian recommendation for the treatment of ME/CFS. However, Orvosi Hetilap received a letter from Jonathan Edwards, professor emeritus at University College London criticising the paper. In their reply, the authors admit that what they wrote in the recommendation does not align with NICE’s latest recommendations, and they no longer recommend the therapies they previously mentioned.
Article | Thread
#MEAction has announced their Severe ME Artists Project for 2025 in recognition of Severe ME Day on August 8th. Anyone who identifies as having severe ME can participate. Submissions are due by July 24.
Article | Thread
USA - Solve ME has an overview of this year's Advocacy Week 2025 on their website. There were a total of 187 meetings with congressional offices, with 226 attendees from across 36 states and Washington, D.C.
Article | Thread
The Sick Times Experts call new Canadian Long COVID guidelines “contradictory” and “deeply concerning”
This article describes problems with the new Long Covid guidelines which include scientifically unsupported therapies such as exercise and cognitive behavioral therapy. Experts say some of these guidelines could harm people with Long COVID.
Article | Thread
.............
Research news and commentary
UK National Institute for Health Research
"The Efficacy and Mechanism Evaluation (EME) Programme is accepting full applications for research looking into the treatment and management of post-acute infection syndromes and associated conditions, including long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)".
Applications close 2nd December 2025. This project is mentioned in a parliamentary written answer.
Information | Thread | Parliamentary answer
Germany
The MIRACLE research project is now recruiting participants. It will investigates immunological, inflammatory, and metabolic pathways in approximately 200 patients with ME/CFS and 200 healthy controls. The project is a collaboration between the University Hospital of Marburg (UKGM) and the University Hospital of Regensburg (UKR).
Article | Thread
The Sick Times Live Blog: Following the Patient-Led Research Fund summer 2025 webinar
Coverage of the July 9 webinar which covered "new findings about the underlying biology of infection-associated chronic conditions (IACCs), as well as discussions about how patient engagement leads to better research."
Blog | Thread
............
Research
ME/CFS research
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study — Fluge et al.
"We performed a prospective, open-label pilot trial" "Six out of 10 patients experienced clinical improvement during follow-up." "there was a significant correlation between baseline number of NK cells in peripheral blood and clinical improvement"
Article | Thread
Oxidative stress is a shared characteristic of ME/CFS and Long COVID — Shankar et al.
"Using a combination of flow cytometry, RNA-seq, mass spectrometry, and systems chemistry analysis, we observed aberrations in reactive oxygen species (ROS) clearance pathways including elevated glutathione levels, decreases in mitochondrial superoxide dismutase protein levels, and glutathione peroxidase 4–mediated lipid oxidative damage. Strikingly, these redox pathways changes show sex-specific trends."
Article | Thread
Patient-reported treatment outcomes in ME/CFS and long COVID — Eckey et al.
"This study analyzes patient-reported outcomes from over 3,900 individuals, identifying treatments perceived as beneficial and uncovering symptom-based patient subgroups with distinct responses to therapies. Notably, there is significant overlap in the symptom profiles and treatment responses between ME/CFS and long COVID, suggesting that they may share underlying mechanisms."
Article | Thread
SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis — Rostami-Afshari et al.
"findings suggest that immune dysregulation in ME may be linked to enhanced cleavage of membrane-bound SMPDL3B by PI-PLC." However forum commentary identified that the study may suffer from inadquate matching between patients and controls.
Article | Thread
Comparing DNA Methylation Landscapes in Peripheral Blood from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Patients — Peppercorn et al.
"A comparative study of the DNA methylation changes in small cohorts of age/sex matched ME/CFS patients and LC patients was compared against similarly matched [healthy controls]."
Article | Thread
Decreased risk of chronic fatigue syndrome following influenza vaccine: a 20-year population-based retrospective study — Chang et al.
Study used a broad definition of CFS. "each cohort comprised 309,692 patients. Over an average follow-up period of approximately 12 years, influenza patients exhibited a significantly increased risk of developing CFS compared to matched controls (aHR = 1.51; 95% CI: 1.48–1.55; p < 0.001)."
Article | Thread
Multifaceted evolution focused on maximal exploitation of domain knowledge for the consensus inference of Gene Regulatory Networks — Segura-Ortiz et al.
"BIO-INSIGHT was applied to gene expression data from patients with fibromyalgia, myalgic encephalomyelitis, and co-diagnosis of both diseases. The inferred networks revealed regulatory interactions specific to each condition, suggesting its clinical utility in biomarker identification and potential therapeutic targets."
Article | Thread
Blood parameters differentiate post COVID-19 condition from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia — Giménez -Orenga et al.
Article | Thread
Long Covid research
Immunological and Clinical Markers of Post-acute Sequelae of COVID-19: Insights from Mild and Severe Cases 6 Months Post-infection — William Mouton et al.
"an indepth analysis of immune parameters in severe patients with and without PASC highlighted that total and N/M-responsive memory T cells from patients with PASC harbored a more terminally differentiated phenotype."
Article | Thread
In Silico Analysis of Post-COVID-19 Condition (PCC) Associated SNP rs9367106 Predicts the Molecular Basis of Abnormalities in the Lungs and Brain Functions — Maiti
"rs9367106 carrying DNA sequences act as distant enhancers and bind with several transcription factors (TFs) including YY1, PPAR-α, IK-1, GR-α, and AP2αA. The G>C transition extensively modifies the RNA structure that may affect the TF bindings and enhancer functions to alter the interactions and functions of these RNA molecules."
Article | Thread
Comprehensive molecular characterization of post-COVID condition: Immunoglobulin suppression and persistent SARS-CoV-2 antigens as key pathophysiological drivers — Seco-Gonzalez et al.
Article | Thread
Validity of the test for attentional performance in neurological post-COVID condition — Seibert et al.
"The TAP subtests identified significant impairments in sustained attention and processing speed in one-third of PCC patients, surpassing traditional tests in sensitivity, and classifying PCC with an AUC of 78%."
Article | Thread
Appropriate Screening Tests to Assess Post-COVID-19 Cognitive Dysfunction in Aeromedical Settings — Solomon G. Beka et al.
"Based on evaluation of literature review findings and Delphi consultation with subject matter experts, the Trail Making Test and Symbol Digit Modalities Test were identified as quick and suitable screening tests likely to detect post-COVID-19 cognitive dysfunction."
Article | Thread
Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland — Kwon et al.
"This study found small improvements in EQ-5D-3L utility score in LC patients receiving care in LC clinics."
Article | Thread
...........
S4ME social media: Forum, Mastodon, Bluesky